| Literature DB >> 30361559 |
Morito Sakikubo1,2, Kenichiro Furuyama1,2, Masashi Horiguchi1,2, Shinichi Hosokawa1,2, Yoshiki Aoyama1,2, Kunihiko Tsuboi1,2, Toshihiko Goto1,2, Koji Hirata1,2, Toshihiko Masui1,2, Yuval Dor3, Tomoyuki Fujiyama4,5, Mikio Hoshino4, Shinji Uemoto1, Yoshiya Kawaguchi6.
Abstract
Pancreas transcription factor 1 subunit alpha (PTF1A) is one of the key regulators in pancreatogenesis. In adults, it transcribes digestive enzymes, but its other functions remain largely unknown. Recent conditional knockout studies using Ptf1aCreER/floxed heterozygous mouse models have found PTF1A contributes to the identity maintenance of acinar cells and prevents tumorigenesis caused by the oncogenic gene Kras. However, Ptf1a heterozygote is known to behave differently from homozygote. To elucidate the effects of Ptf1a homozygous loss, we prepared Elastase-CreERTM; Ptf1afloxed/floxed mice and found that homozygous Ptf1a deletion in adult acinar cells causes severe apoptosis. Electron microscopy revealed endoplasmic reticulum (ER) stress, a known cause of unfolded protein responses (UPR). We confirmed that UPR was upregulated by the activating transcription factor 6 (ATF6) and protein kinase RNA (PKR)-like endoplasmic reticulum kinase (PERK) pathways, but not the inositol requiring enzyme 1 (IRE1) pathway. Furthermore, we detected the expression of CCAAT-enhancer-binding protein (C/EBP) homologous protein (CHOP), a pro-apoptotic factor, indicating the apoptosis was induced through UPR. Our homozygous model helps clarify the role PTF1A has on the homeostasis and pathogenesis of exocrine pancreas in mice.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30361559 PMCID: PMC6202406 DOI: 10.1038/s41598-018-34093-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Acinar-specific Ptf1a deletion decreased pancreatic volume through activated apoptosis. (a) Representative pancreatic appearance of control and Ptf1a cKO mice on day 10. (b) Relative pancreatic weight per body weight. control, n = 3; Ptf1a cKO, n = 3. (c) The number of TUNEL or BrdU positive acinar cells per mm2 on day 3 or 10. control, n = 3; Ptf1a cKO, n = 3. *P < 0.05.
Figure 2Lineage tracing revealed activated apoptosis and compensatory proliferation in Ptf1a cKO pancreata. (a) Representative figures of control and Ptf1a cKO mice on day 3 and day 10 stained by X-gal and Nuclear Fast Red. (b) The ratio of X-gal labeled acinar cells. control, n = 3; Ptf1a cKO, n = 3. (c) Representative figures of TUNEL staining with X-gal and hematoxylin staining, and the number of TUNEL(+) acinar cells per mm2 on day 3. (d) Representative figure of BrdU staining with X-gal and hematoxylin staining, and the ratio of X-gal(+)BrdU(+) cells per total BrdU(+) cells compared with the ratio of X-gal(+)cells in Ptf1a cKO mice on day 3. Arrowheads indicate an X-gal(−)TUNEL(+) nucleus in (c) or X-gal(−)BrdU(+) nuclei in (d) in Ptf1a cKO mice. Scale bars = 100 μm (a) or 25 μm (c,d). *P < 0.05.
Figure 3Activated endoplasmic reticulum stress in acinar cells of Ptf1a cKO mice. Representative findings of electron microscopy in control mice on day 3 (a) in Ptf1a cKO mice on day 3 (c) in control mice on day 10 (e) and in Ptf1a cKO mice on day 10 (g). (b,d,f,h) are magnified images of (a,c,e,g). Note the dilated ER lumen (indicated by red asterisks) in Ptf1a cKO mice on day 3 (d). Scale bars = 2 μm.
Figure 4Cleavage of ATF6 was upregulated in Ptf1a cKO mice on day 3 but recovered by day 10. (a) Western blotting of control and Ptf1a cKO mice on day 3. (b) Comparison of the ratio of total ATF6/GAPDH expression in control and Ptf1a cKO mice on day 3. (c) Comparison of the ratio of cleaved ATF6/total ATF6 expression in control and Ptf1a cKO mice on day 3. (d) Western blotting of control and Ptf1a cKO mice on day 10. (e) Comparison of the ratio of total ATF6/GAPDH expression in control and Ptf1a cKO mice on day 10. (f) Comparison of the ratio of cleaved ATF6/total ATF6 expression in control and Ptf1a cKO mice on day 10. f-ATF6: full length ATF6, c-ATF6: cleaved ATF6. control, n = 4; Ptf1a cKO, n = 4. *P < 0.05. The original, unprocessed scans of the blots are shown in Supplementary Fig. S5.
Figure 5Splicing of Xbp1 mRNA was suppressed in Ptf1a cKO mice on day 3 but recovered by day 10. (a) Representative electrophoresis of RT-PCR products of unspliced and spliced Xbp1 mRNA on day 3. (b) Comparison of the percentage of spliced Xbp1 mRNA on day 3 in control and Ptf1a cKO mice. control, n = 5; Ptf1a cKO, n = 6. (c) Representative electrophoresis of RT-PCR products of unspliced and spliced Xbp1 mRNA on day 10. (d) Comparison of the percentage of spliced Xbp1 mRNA on day 10 in control and Ptf1a cKO mice. control, n = 6; Ptf1a cKO, n = 5. *P < 0.05. The original, unprocessed scans of the gels are shown in Supplementary Fig. S6.
Figure 6ATF4 and CHOP were upregulated in Ptf1a cKO mice on day 3 but recovered by day 10. Immunofluorescence of (a) PTF1A and ATF4 (b) ATF4 and CHOP, and (c) PTF1A and CHOP with hematoxylin-eosin staining on days 3 and 10. Arrowheads indicate CHOP and ATF4 double positive nuclei in (b) or a PTF1A and CHOP double positive nucleus in (c). Hematoxylin-eosin was stained on the same sections after immunofluorescence. Scale bars = 50 μm.